- $1.99bn
- $1.79bn
- $5.93bn
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
U.S. STOCKS ON THE MOVE-Albemarle, Howmet, Travere Therapeutics
Agilon Health jumps after raising outlook, beating quarterly profit views
U.S. RESEARCH ROUNDUP-ARM Holdings, CDW, Doordash
Agilon Health Q1 revenue beats estimates, raises 2026 guidance
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx
Agilon Health falls after J.P. Morgan downgrades co to 'underweight'
Agilon Health Q4 revenue beats estimates
Brief: Agilon Health Q4 Revenue USD 1,570 Million Vs. IBES Estimate USD 1,461 Million
Brief: agilon Announces Receipt Of Notice Of Non-Compliance With The NYSE Continued Listing Standards
Agilon Health Q3 revenue beats estimates
Brief: Agilon Health Q3 Revenue USD 1,440 Million Vs. IBES Estimate USD 1,427 Million
agilon health inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Agilon Health Q2 Revenue USD 1,400 Million Vs. IBES Estimate USD 1,471 Million
agilon health inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Agilon Health Q1 Revenue USD 1,530 Million Vs. IBES Estimate USD 1,504 Million